LORBRENA® is a prescription medicine that is used to treat people with non-small cell lung cancer (NSCLC)
- that is caused by an abnormal anaplastic lymphoma kinase (ALK) gene, and
- that has spread to other parts of the body, and
- who have taken the medicine:
- alectinib, or ceritinib, or
- both crizotinib and at least 1 other medicine to treat NSCLC that is caused by the ALK gene, and
- that is no longer responding to these treatments.
It is not known if LORBRENA is safe and effective in children.
The effectiveness of LORBRENA is based on a study that measured tumor response rate and duration of response. There is an ongoing study to find out how LORBRENA works over a longer period of time.
real patient stories
Hear from real LORBRENA patients about their experiences navigating diagnosis and their treatment journey.
If your doctor prescribed LORBRENA, it’s important to understand the treatment and also the potential side effects that you may experience. As you begin treatment with LORBRENA, it may be helpful to learn more about what to expect.What to expect
Eligible, commercially insured patients may pay as little as $0 per month for LORBRENA.* There are no income requirements, forms, or faxing to enroll.
*Limits, terms, and conditions apply. Patients are not eligible to use this card if they are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico. Patients may receive up to $25,000 in savings annually. The offer will be accepted only at participating pharmacies. This offer is not health insurance. No membership fees apply. Pfizer reserves the right to rescind, revoke, or amend this offer without notice. For any questions, please call
ALK=anaplastic lymphoma kinase; NSCLC=non-small cell lung cancer.